Limiting Adverse Birth Outcomes in Resource-Limited Settings

NCT ID: NCT04102644

Last Updated: 2022-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

12020 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-31

Study Completion Date

2022-09-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this research is to exhaustively document the course and outcomes of hospitalization, labor, delivery, and early postpartum course of up to 15,000 mother-newborn pairs in settings where the occurrence of adverse outcomes is high. The Investigators will gather detailed laboratory, physiologic, and clinical information, and precisely characterize major adverse diagnoses and outcomes. The resulting high-quality, granular, and generalizable data will be used to develop new algorithms to signal actionable intrapartum diagnoses and prospectively stratify women according to their risk for adverse maternal and neonatal outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective multi-country cohort study of up to 15,000 women admitted to the hospital for delivery or for management of respiratory infection. Women will be recruited and screened for study participation at the time of presentation to the hospital. Participants will be assessed through hospitalization, labor, delivery, and discharge and at 1- and 6-week postpartum contacts. Liveborn infants will be enrolled at birth and followed through 42 days of life. The pilot phase of this protocol will enroll up to 500 women in labor and their newborns and follow them through labor, delivery, and 42 days postpartum.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Birth Outcomes Labor and Delivery Respiratory Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregnant Women

Up to 15,000 pregnant women and their fetuses/newborns (including a pilot phase of up to 500 participant pairs)

Observation

Intervention Type OTHER

Documentation of course and outcome of hospitalization, labor, delivery, and postpartum period

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observation

Documentation of course and outcome of hospitalization, labor, delivery, and postpartum period

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Maternal age of majority
* Intrauterine singleton pregnancy
* Admission to the hospital for ANY of the following:

1. vaginal delivery
2. cesarean delivery in the presence of signs/symptoms of parturition, elevated blood pressure, or fever
3. management of respiratory infection\*
* Ability and willingness to provide written informed consent
* Willingness to adhere to study procedures
* Willingness to provide locator information for follow-up

* Inclusion of participants admitted to hospital for management of respiratory infection applicable to Zambia site only.

Exclusion Criteria

* Admission to the hospital for cesarean delivery in the absence of signs/symptoms of parturition, elevated blood pressure, or fever
* Any condition (social or medical) that, in the opinion of study staff, would make participation unsafe or not feasible. Study staff may note physical, psychological, or social conditions that are not explicitly stated in the eligibility criteria that could make some women poor candidates for study participation.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bill and Melinda Gates Foundation

OTHER

Sponsor Role collaborator

University of North Carolina, Chapel Hill

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jeff Stringer, MD, FACOG

Role: PRINCIPAL_INVESTIGATOR

University of North Carolina, Chapel Hill

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Korle Bu Teaching Hospital,

Accra, , Ghana

Site Status

Jawaharlal Nehru Medical College Women's and Children's Health Research Unit, KLE Academy of Higher Education and Research

Belagavi, Karnataka, India

Site Status

Fakir Mohan Medical College and Hospital

Balasore, Odisha, India

Site Status

Women and Newborn Hospital at University Teaching Hospital

Lusaka, , Zambia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ghana India Zambia

References

Explore related publications, articles, or registry entries linked to this study.

Walter JR, Xu S, Rogers JA. From lab to life: how wearable devices can improve health equity. Nat Commun. 2024 Jan 2;15(1):123. doi: 10.1038/s41467-023-44634-9.

Reference Type DERIVED
PMID: 38167483 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Z 31902

Identifier Type: OTHER

Identifier Source: secondary_id

19-0765

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Oral Intake During Labor
NCT03276741 TERMINATED NA
Fever During Labour
NCT04164875 UNKNOWN
Outpatient Birth: Pilot Study
NCT03815227 COMPLETED NA